Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06580548 · ClinicalTrials.gov registry record · NA

A New At-home Telerehabilitation Care Service Delivery Model for Stroke Survivors in the Rio Grande Valley

A NA study of Stroke, sponsored by The University of Texas Health Science Center, Houston.

Active
Registry status
NA
Development phase
11
Enrollment target
1
Study location

NCT06580548: Active NA study of Stroke, sponsored by The University of Texas Health Science Center, Houston.

NCT06580548 is a NA study of Stroke that is active but no longer recruiting, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 11 participants, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06580548, a NA study of Stroke, is active but no longer recruiting, sponsored by The University of Texas Health Science Center, Houston.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
11 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to investigate the feasibility of a mobile telerehabilitation software for post-acute stroke care for Rio Grande Valley (RGV) stroke survivors with community health worker (CHW) at-home support and to estimate the functional health, mental health (depression), and caregiver burden outcomes of this new CHW-supported, at-home rehabilitation service delivery model and to identify salient barriers to and facilitators of adopting and delivering the new rehabilitation delivery model to further disseminate the model in real-world communities.

Primary Outcome

This is an 18 item questionnaire and each is scored from 1(unable) to 4( none) for a score range of 1-72, higher score indicating better outcome

Conditions Studied

Interventions

  • OTHER Usual Care
  • DEVICE CHW-supported telerehabilitation

Study Locations (1)

Texas

  • The University of Texas Health Science Center at Houston - Houston

Trial Details

FieldValue
Enrollment Target 11 participants
Start Date 2025-03-17
Est. Completion 2026-05-01
Phase NA

What the registry record for NCT06580548 still lists

NCT06580548 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 11 participants, a relatively small participant target, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (100% lower).

The record links to 1 condition, with Stroke appearing as the primary indexed condition, and to 2 interventions - of which Usual Care is the first listed.

NCT06580548 reports a single indexed study location in Texas.

Frequently Asked Questions

What is clinical trial NCT06580548 about?

NCT06580548 is a clinical study titled "A New At-home Telerehabilitation Care Service Delivery Model for Stroke Survivors in the Rio Grande Valley". The purpose of this study is to investigate the feasibility of a mobile telerehabilitation software for post-acute stroke care for Rio Grande Valley (RGV) stroke survivors with community health worker (CHW) at-home support and to estimate the functional health, mental health (depression), and caregi...

What is the current status of trial NCT06580548?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 11 participants. The study started on 2025-03-17. Estimated completion is 2026-05-01.

What conditions does trial NCT06580548 study?

This clinical trial studies the following conditions: Stroke.

What interventions are being tested in trial NCT06580548?

The interventions under investigation include: Usual Care (OTHER), CHW-supported telerehabilitation (DEVICE).

Who is sponsoring clinical trial NCT06580548?

This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06580548 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Stroke

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06580548's enrollment target sits among peer trials

11 409th of 454 higher than 41 of 454 other Stroke trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Stroke trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03114462 · 11 participants · Phase 1

    Trial of Stereotactic HYpofractionateD RadioAblative (HYDRA) Treatment of Laryngeal Cancer

  • NCT06039709 · 11 participants · Phase 1

    Sonodynamic Therapy in Patients With Recurrent GBM

  • NCT06425380 · 11 participants · NA

    Pilot Open-Label Trial of Resistant Potato Starch in Patients With Cirrhosis and Overt Hepatic Encephalopathy

  • NCT06472661 · 11 participants · Early Phase 1

    FUSA With Intratumoral PolyICLC in Regionally Advanced Resectable Melanoma

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06580548, the US trial registry maintained by the National Library of Medicine. NCT06580548 (small enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.